Assessing the Effect of Pomalidomide or Carfilzomib Treatment on Patient-Reported Outcomes Among Patients With Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Gupta, Shaloo [1 ]
Clancy, Zoe [2 ]
Copher, Ronda [2 ]
Rosenberg, Aaron Seth [3 ]
机构：
[1] Kantar, New York, NY USA
[2] Celgene Corp, Summit, NJ USA
[3] Univ Calif Davis, Comprehens Canc Ctr, Div Hematol & Oncol, Sacramento, CA 95817 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Multiple myeloma; Patient Reported Measures; Pomalidomide;
D O I：
10.1016/j.clml.2019.09.443
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-117
引用
收藏
页码：E268 / E269
页数：3
相关论文
共 50 条
  • [21] Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data
    Offidani, Massimo
    Corvatta, Laura
    Caraffa, Patrizia
    Leoni, Pietro
    Pautasso, Chiara
    Larocca, Alessandra
    Palumbo, Antonio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 499 - 510
  • [22] Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
    Chari, Ajai
    Martinez-Lopez, Joaquin
    Mateos, Maria-Victoria
    Blade, Joan
    Benboubker, Lotfi
    Oriol, Albert
    Arnulf, Bertrand
    Rodriguez-Otero, Paula
    Pineiro, Luis
    Jakubowiak, Andrzej
    de Boer, Carla
    Wang, Jianping
    Clemens, Pamela L.
    Ukropec, Jon
    Schecter, Jordan
    Lonial, Sagar
    Moreau, Philippe
    BLOOD, 2019, 134 (05) : 421 - 431
  • [23] Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis
    Chen, Runzhe
    Wang, Yujie
    Luan, Chengxin
    Gao, Chong
    Zhang, Xiaoping
    Chen, Baoan
    JOURNAL OF CANCER, 2017, 8 (10): : 1801 - 1808
  • [24] Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
    Zhou, Xiang
    Fluechter, Patricia
    Nickel, Katharina
    Meckel, Katharina
    Messerschmidt, Janin
    Boeckle, David
    Knorz, Sebastian
    Steinhardt, Maximilian Johannes
    Krummenast, Franziska
    Danhof, Sophia
    Einsele, Hermann
    Kortuem, K. Martin
    Rasche, Leo
    CANCERS, 2020, 12 (04)
  • [25] The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone
    Nakayama, Hitomi
    Aisa, Yoshinobu
    Ito, Chisako
    Sakurai, Aki
    Nakazato, Tomonori
    HEMATOLOGY REPORTS, 2024, 16 (04) : 593 - 602
  • [26] Pomalidomide and Dexamethasone Treatment for ≥ 1 Year in Renally Impaired Patients With Relapsed or Refractory Multiple Myeloma
    Weisel, Katja
    Dimopoulos, Meletios A.
    Cook, Mark
    Ramasamy, Karthik
    De La Rubia, Javier
    Ardizzoia, Antonio
    Krauth, Maria Theresa
    Jaccard, Arnaud
    Van de Donk, Niels
    Kueenburg, Elisabeth
    Di Micco, Antonia
    Rosettani, Barbara
    Atiba-Davies, Margaret
    Bacon, Pamela
    Sonneveld, Pieter
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E284 - E285
  • [27] Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients
    Nooka, Ajay K.
    Joseph, Nisha S.
    Kaufman, Jonathan L.
    Heffner, Leonard T.
    Gupta, Vikas A.
    Gleason, Charise
    Boise, Lawrence H.
    Lonial, Sagar
    CANCER, 2019, 125 (17) : 2991 - 3000
  • [28] Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS
    Qian, Xiaozhong
    Dimopoulos, Meletios A.
    Amatangelo, Michael
    Bjorklund, Chad
    Towfic, Fadi
    Flynt, Erin
    Weisel, Katja C.
    Ocio, Enrique M.
    Yu, Xin
    Peluso, Teresa
    Sternas, Lars
    Zaki, Mohamed
    Moreau, Philippe
    Thakurta, Anjan
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 462 - 470
  • [29] Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel
    Oswald, Laura B.
    Gudenkauf, Lisa M.
    Li, Xiaoyin
    De Avila, Gabriel
    Peres, Lauren C.
    Kirtane, Kedar
    Gonzalez, Brian D.
    Hoogland, Aasha I.
    Nguyen, Oanh
    Rodriguez, Yvelise
    Baz, Rachid C.
    Shain, Kenneth H.
    Alsina, Melissa
    Locke, Frederick L.
    Freeman, Ciara
    Castaneda Puglianini, Omar
    Nishihori, Taiga
    Liu, Hien
    Blue, Brandon
    Grajales-Cruz, Ariel
    Jim, Heather S. L.
    Hansen, Doris K.
    CANCERS, 2023, 15 (19)
  • [30] Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma
    Jain, Salvia
    Diefenbach, Catherine
    Zain, Jasmine
    O'Connor, Owen A.
    CORE EVIDENCE, 2011, 6 : 43 - 57
12345